Collier Kathryn J - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, Collier Kathryn J's relationship to Regulus Therapeutics Inc. (RGLS) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RGLS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Collier Kathryn J - Insider Non-Derivative Transactions of RGLS Common Stock

Collier Kathryn J - Insider Non-Derivative Transactions at RGLS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Disposition -- (Common Stock)	75565	0	0
Jun 18, 2025	M -- (Common Stock)	2325	8.8	62915
Jun 18, 2025	M -- (Common Stock)	2604	9.9	65240
Jun 17, 2025	M -- (Common Stock)	1396	9.9	67844
May 1, 2025	Acquisition -- (Common Stock)	62500	0	69240
Jul 26, 2024	P -- (Common Stock)	4000	1.82	6740